This study expands the understanding of SHROOM2’s expression profile across cancers and its relationship with tumor immunity, identifying SHROOM2 as a potential oncogene and an immune infiltration-related biomarker, particularly in BC. This evidence concerns the gene SHROOM2 and cancer.